DJ
Therapeutic Areas
Aquilus Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AQU-118 | Amyotrophic Lateral Sclerosis (ALS) | Phase 1 |
Leadership Team at Aquilus Pharmaceuticals
IS
Irving Sucholeiki, Ph.D.
President & Chief Executive Officer
RS
Roy Sucholeiki, M.D.
CMO & Vice President, Clinical Development